8,918
Views
124
CrossRef citations to date
0
Altmetric
Editor's Corner

Antibody-drug conjugates

Present and future

&
Pages 15-17 | Published online: 05 Dec 2013

References

  • Beck A, Haeuw JF, Wurch T, Goetsch L, Bailly C, Corvaïa N. The next generation of antibody-drug conjugates comes of age. Discov Med 2010; 10:329 - 39; PMID: 21034674
  • Reichert JM. Antibodies to watch in 2014. MAbs 2013; 6; In press PMID: 24284914
  • Wagner-Rousset E, Janin-Bussat MC, Colas O, Excoffier M, Haeuw JF, Rilatt I, Perez M, Corvaïa N, Beck A. Antibody Drug Conjugate model fast characterization by LC-MS following IdeS proteolytic digestion. MAbs 2013; 6; Forthcoming 2013 PMID: 24135617
  • Beck A. Review of Antibody-Drug Conjugates, Methods in Molecular Biology series: A book edited by Laurent Ducry, mAbs 2014; 6: in press.
  • Beck A, Wurch T, Bailly C, Corvaïa N. Strategies and challenges for the next generation of therapeutic antibodies. Nat Rev Immunol 2010; 10:345 - 52; http://dx.doi.org/10.1038/nri2747; PMID: 20414207
  • Junutula JR, Raab H, Clark S, Bhakta S, Leipold DD, Weir S, Chen Y, Simpson M, Tsai SP, Dennis MS, et al. Site-specific conjugation of a cytotoxic drug to an antibody improves the therapeutic index. Nat Biotechnol 2008; 26:925 - 32; http://dx.doi.org/10.1038/nbt.1480; PMID: 18641636
  • Shen BQ, Xu K, Liu L, Raab H, Bhakta S, Kenrick M, Parsons-Reponte KL, Tien J, Yu SF, Mai E, et al. Conjugation site modulates the in vivo stability and therapeutic activity of antibody-drug conjugates. Nat Biotechnol 2012; 30:184 - 9; http://dx.doi.org/10.1038/nbt.2108; PMID: 22267010
  • Panowksi S, Bhakta S, Raab H, Polakis P, Junutula JR. Site-specific antibody drug conjugates for cancer therapy. MAbs 2014; 6; Forthcoming 2013 http://dx.doi.org/10.4161/mabs.27022
  • Behrens CR, Liu B. Methods for site-specific drug conjugation to antibodies. MAbs 2013; 6; In press PMID: 24135651
  • Wakankar A, Chen Y, Gokarn Y, Jacobson FS. Analytical methods for physicochemical characterization of antibody drug conjugates. MAbs 2011; 3:161 - 72; http://dx.doi.org/10.4161/mabs.3.2.14960; PMID: 21441786
  • Beck A, Wagner-Rousset E, Ayoub D, Van Dorsselaer A, Sanglier-Cianférani S. Characterization of therapeutic antibodies and related products. Anal Chem 2013; 85:715 - 36; http://dx.doi.org/10.1021/ac3032355; PMID: 23134362
  • Rosati S, van den Bremer ET, Schuurman J, Parren PW, Kamerling JP, Heck AJ. In-depth qualitative and quantitative analysis of composite glycosylation profiles and other micro-heterogeneity on intact monoclonal antibodies by high-resolution native mass spectrometry using a modified Orbitrap. MAbs 2013; 5:917 - 24; http://dx.doi.org/10.4161/mabs.26282; PMID: 23995615
  • Beck A, Senter P, Chari R. World Antibody Drug Conjugate Summit Europe: February 21-23, 2011; Frankfurt, Germany. MAbs 2011; 3:331 - 7; http://dx.doi.org/10.4161/mabs.3.4.16612; PMID: 21691144
  • Beck A, Lambert J, Sun M, Lin K. Fourth World Antibody-Drug Conjugate Summit: February 29-March 1, 2012, Frankfurt, Germany. MAbs 2012; 4:637 - 47; http://dx.doi.org/10.4161/mabs.21697; PMID: 22909934
  • Klinguer-Hamour C, Strop P, Shah DK, Ducry L, Xu A, Beck A. World Antibody-Drug Conjugate Summit, October 15-16, 2013, San Francisco, CA. MAbs 2014; 6 Forthcoming 2014
  • Beck A, Hanala S, Reichert JM. 4th European Antibody Congress 2008: December 1-3, 2008, Geneva, Switzerland. MAbs 2009; 1:93 - 103; http://dx.doi.org/10.4161/mabs.1.2.7890; PMID: 20061813
  • Beck A, Reichert JM, Wurch T. 5th European Antibody Congress 2009: November 30?December 2, 2009, Geneva, Switzerland. MAbs 2010; 2:108 - 28; http://dx.doi.org/10.4161/mabs.2.2.11302; PMID: 20179425
  • Beck A, Wurch T, Reichert JM. 6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland. MAbs 2011; 3:111 - 32; http://dx.doi.org/10.4161/mabs.3.2.14788; PMID: 21441785
  • Lugovskoy AA, Reichert JM, Beck A. 7th Annual European Antibody Congress 2011: November 29-December 1, 2011, Geneva, Switzerland. MAbs 2012; 4:134 - 52; http://dx.doi.org/10.4161/mabs.4.2.19426; PMID: 22453093
  • Beck A, Carter PJ, Gerber HP, Lugowskoy AA, Wurch T, Junutula JR, Kontermann K, Mabry R. 8th Annual European Antibody Congress 2012: November 27-28, 2012, Geneva, Switzerland. MAbs 2013; 5:339 - 57; http://dx.doi.org/10.4161/mabs.24105
  • Pauwels PJ, Dumontet C, Reichert JM, Beck A, Goetsch L, Corvaia N, Klein C, Coiffier B, Teicher B. 7th cancer scientific forum of theCancéropôle Lyon Auvergne Rhône-Alpes: March 20-21, 2012, Lyon, France. MAbs 2012; 4:434 - 44; http://dx.doi.org/10.4161/mabs.20869; PMID: 22684281
  • Ho M, Royston I, Beck A. 2nd PEGS Annual Symposium on Antibodies for Cancer Therapy: April 30-May 1, 2012, Boston, USA. MAbs 2012; 4:562 - 70; http://dx.doi.org/10.4161/mabs.21521; PMID: 22864478